Immune cytolytic activity is associated with reduced intra-tumoral genetic heterogeneity and with better clinical outcomes in triple negative breast cancer.
Oshi M, Kawaguchi T, Yan L, Peng X, Qi Q, Tian W, Schulze A, McDonald KA, Narayanan S, Young J, Liu S, Morris LG, Chan TA, Kalinski P, Matsuyama R, Otsuji E, Endo I, Takabe K.
Oshi M, et al. Among authors: young j.
Am J Cancer Res. 2021 Jul 15;11(7):3628-3644. eCollection 2021.
Am J Cancer Res. 2021.
PMID: 34354864
Free PMC article.